BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 35626699)

  • 21. A novel lncRNA-miRNA-mRNA competing endogenous RNA regulatory network in lung adenocarcinoma and kidney renal papillary cell carcinoma.
    Zhou Q; Li D; Zheng H; He Z; Qian F; Wu X; Yin Z; Bao PT; Jin M
    Thorac Cancer; 2021 Oct; 12(19):2526-2536. PubMed ID: 34453499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A panel of eight autophagy-related long non-coding RNAs is a good predictive parameter for clear cell renal cell carcinoma.
    Gui CP; Cao JZ; Tan L; Huang Y; Tang YM; Li PJ; Chen YH; Lu J; Yao HH; Chen ZH; Pan YH; Ye YL; Qin ZK; Chen W; Wei JH; Luo JH
    Genomics; 2021 Mar; 113(2):740-754. PubMed ID: 33516849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Warthin-like papillary renal cell carcinoma: Clinicopathologic, morphologic, immunohistochemical and molecular genetic analysis of 11 cases.
    Skenderi F; Ulamec M; Vanecek T; Martinek P; Alaghehbandan R; Foix MP; Babankova I; Montiel DP; Alvarado-Cabrero I; Svajdler M; Dubinský P; Cempirkova D; Pavlovsky M; Vranic S; Daum O; Ondic O; Pivovarcikova K; Michalova K; Hora M; Rotterova P; Stehlikova A; Dusek M; Michal M; Hes O
    Ann Diagn Pathol; 2017 Apr; 27():48-56. PubMed ID: 28325361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression Profiles and Clinical Significance of MicroRNAs in Papillary Renal Cell Carcinoma: A STROBE-Compliant Observational Study.
    Ge YZ; Xu LW; Xu Z; Wu R; Xin H; Zhu M; Lu TZ; Geng LG; Liu H; Zhou CC; Yu P; Zhao YC; Hu ZK; Zhao Y; Zhou LH; Wu JP; Li WC; Zhu JG; Jia RP
    Medicine (Baltimore); 2015 Apr; 94(16):e767. PubMed ID: 25906110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Review of Recent Research on the Role of MicroRNAs in Renal Cancer.
    Yang L; Zou X; Zou J; Zhang G
    Med Sci Monit; 2021 May; 27():e930639. PubMed ID: 33963171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromosomal numerical aberration pattern in papillary renal cell carcinoma: Review article.
    Pitra T; Pivovarcikova K; Alaghehbandan R; Hes O
    Ann Diagn Pathol; 2019 Jun; 40():189-199. PubMed ID: 29454759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long Non-Coding RNA Emergence During Renal Cell Carcinoma Tumorigenesis.
    Liu X; Hao Y; Yu W; Yang X; Luo X; Zhao J; Li J; Hu X; Li L
    Cell Physiol Biochem; 2018; 47(2):735-746. PubMed ID: 29794462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and Validation of Two Novel Prognostic lncRNAs in Kidney Renal Clear Cell Carcinoma.
    Song J; Peng J; Zhu C; Bai G; Liu Y; Zhu J; Liu J
    Cell Physiol Biochem; 2018; 48(6):2549-2562. PubMed ID: 30121668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a Two-m6A RNA Methylation Regulator Risk Signature as an Independent Prognostic Biomarker in Papillary Renal Cell Carcinoma by Bioinformatic Analysis.
    Yang F; Zhao G; Ge L; Song Y; Hong K; Zhang H; Liu C; Hong P; Ma L
    Biomed Res Int; 2021; 2021():4582082. PubMed ID: 33628782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Three-gene risk model in papillary renal cell carcinoma: a robust likelihood-based survival analysis.
    Wang Y; Yan K; Lin J; Wang J; Zheng Z; Li X; Hua Z; Bu Y; Shi J; Sun S; Li X; Liu Y; Bi J
    Aging (Albany NY); 2020 Nov; 12(21):21854-21873. PubMed ID: 33154194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating RNA in Kidney Cancer: What We Know and What We Still Suppose.
    Cinque A; Vago R; Trevisani F
    Genes (Basel); 2021 May; 12(6):. PubMed ID: 34071652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-cell chromatin accessibility landscape in kidney identifies additional cell-of-origin in heterogenous papillary renal cell carcinoma.
    Wang Q; Zhang Y; Zhang B; Fu Y; Zhao X; Zhang J; Zuo K; Xing Y; Jiang S; Qin Z; Li E; Guo H; Liu Z; Yang J
    Nat Commun; 2022 Jan; 13(1):31. PubMed ID: 35013217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defining candidate mRNA and protein EV biomarkers to discriminate ccRCC and pRCC from non-malignant renal cells in vitro.
    Zieren RC; Dong L; Clark DJ; Kuczler MD; Horie K; Moreno LF; Lih TM; Schnaubelt M; Vermeulen L; Zhang H; de Reijke TM; Pienta KJ; Amend SR
    Med Oncol; 2021 Jul; 38(9):105. PubMed ID: 34331598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a competing endogenous RNA network related to immune signature in clear cell renal cell carcinoma.
    Zhang Y; Dai J; Huang W; Chen Q; Chen W; He Q; Chen F; Zhang P
    Aging (Albany NY); 2021 Dec; 13(24):25980-26002. PubMed ID: 34958632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cystic and necrotic papillary renal cell carcinoma: prognosis, morphology, immunohistochemical, and molecular-genetic profile of 10 cases.
    Peckova K; Martinek P; Pivovarcikova K; Vanecek T; Alaghehbandan R; Prochazkova K; Montiel DP; Hora M; Skenderi F; Ulamec M; Rotterova P; Daum O; Ferda J; Davidson W; Ondic O; Dubova M; Michal M; Hes O
    Ann Diagn Pathol; 2017 Feb; 26():23-30. PubMed ID: 28038707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted next-generation sequencing and non-coding RNA expression analysis of clear cell papillary renal cell carcinoma suggests distinct pathological mechanisms from other renal tumour subtypes.
    Lawrie CH; Larrea E; Larrinaga G; Goicoechea I; Arestin M; Fernandez-Mercado M; Hes O; Cáceres F; Manterola L; López JI
    J Pathol; 2014 Jan; 232(1):32-42. PubMed ID: 24155122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased expression of long non-coding RNA NBAT-1 is associated with poor prognosis in patients with clear cell renal cell carcinoma.
    Xue S; Li QW; Che JP; Guo Y; Yang FQ; Zheng JH
    Int J Clin Exp Pathol; 2015; 8(4):3765-74. PubMed ID: 26097558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrated Molecular Analysis of Papillary Renal Cell Carcinoma and Precursor Lesions Unfolds Evolutionary Process from Kidney Progenitor-Like Cells.
    Saleeb RM; Farag M; Ding Q; Downes M; Bjarnason G; Brimo F; Plant P; Rotondo F; Lichner Z; Finelli A; Yousef GM
    Am J Pathol; 2019 Oct; 189(10):2046-2060. PubMed ID: 31381885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In silico DNA methylation analysis identifies potential prognostic biomarkers in type 2 papillary renal cell carcinoma.
    Yang M; Hlady RA; Zhou D; Ho TH; Robertson KD
    Cancer Med; 2019 Sep; 8(12):5760-5768. PubMed ID: 31361072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual biomarkers long non-coding RNA GAS5 and microRNA-34a co-expression signature in common solid tumors.
    Toraih EA; Alghamdi SA; El-Wazir A; Hosny MM; Hussein MH; Khashana MS; Fawzy MS
    PLoS One; 2018; 13(10):e0198231. PubMed ID: 30289954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.